Searched for
CHRONIC RESPIRATORY DISEASE
These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...29 May, 2026, 05.30 AM IST
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...29 May, 2026, 12.57 AM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Can a cough reveal lung disease? Swaasa AI uses cough sound analysis to screen respiratory disordersAI-powered platform Swaasa is using cough sound analysis through smartphones to help screen respiratory diseases such as COPD, asthma and p...07 May, 2026, 05.30 PM IST
- From care to commerce: How phydigital healthcare is turning patient programmes into big businessIndia's healthcare is changing. Value is moving from hospitals to patients' daily lives. A new 'phydigital' model combines physical and dig...06 May, 2026, 08.28 PM IST
- Anbumani Ramadoss, who banned public smoking during UPA govt, asks PM Modi to bar cigarette sales to those born after 2009PMK leader Anbumani Ramadoss has urged Prime Minister Narendra Modi to enact legislation prohibiting cigarette sales to individuals born af...02 May, 2026, 01.44 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Not just hot days, hot nights are the real problem: Why heatwave health impact and risk increases after sunsetHot nights are emerging as a serious health risk, especially during ongoing heatwaves across India. When temperatures remain high after sun...27 Apr, 2026, 07.09 PM IST
- Heavy Air in Your Bedroom? The Invisible Dirt You’re Breathing at NightYour bedroom air may not be as pure as you think. Tiny particles, dust mites, and chemicals fill the air you breathe at night. This hidden ...20 Apr, 2026, 04.30 PM IST
- Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...17 Apr, 2026, 12.08 AM IST
- Diets high in ultra-processed foods raise death risk from chronic lung conditions, study findsA diet having more than 40 per cent of ultra-processed foods was found to have a 26 per cent higher risk of death from chronic obstructive ...11 Apr, 2024, 11.39 PM IST
- Respiratory infections in a child could lead to death as an adult: StudyThe first-of-its-kind study spanning over seven decades suggests that people who had a lower-respiratory-tract infection (LRTI), such as br...08 Mar, 2023, 12.39 AM IST
- Decoded: Why COVID-19 is more severe in older people than youngThis study reported more severe disease outcomes in patients with hypertension.24 Mar, 2020, 12.34 PM IST
- Suffered asthma in childhood? Can impact workplace productivityAsthma is one of the most common chronic diseases among children, and can interfere with daily life.17 Sep, 2018, 05.30 PM IST
- Air pollution tied to top two causes of death in IndiaAir pollution is an important risk factor for top two causes of death in the country-ischemic heart disease and chronic obstructive pulmona...12 Mar, 2016, 06.54 AM IST
- DRL identifies anti-inflammatory drug for pre-clinical trialPharmaceuticals major Dr Reddy's Laboratories and its UK-based partner Argenta Discovery on Monday said they have selected the first candid...26 Nov, 2007, 04.52 PM IST
Load More
